Medicare Enrolled
Dr. Matthew McMenemy, MD
Glaucoma Specialist (Ophthalmology) Physician · Sugar Land, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McMenemy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McMenemy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McMenemy
Dr. Matthew McMenemy is a glaucoma specialist physician in Sugar Land, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. McMenemy performed 14,756 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McMenemy received a total of $212,233 from 41 pharmaceutical and/or device companies across 682 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McMenemy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 4% volume in TX
$212,233 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗14,756
Medicare services
Top 4% in TX for glaucoma specialist (ophthalmology) physician
Not available
Unique patients (not deduplicated)
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Measurement of corneal pressure | 4,030 | $8 | $25 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
3,269 | $81 | $243 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
1,356 | $61 | $125 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
1,316 | $27 | $167 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
845 | $42 | $170 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
677 | $25 | $147 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
634 | $18 | $145 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
629 | $23 | $168 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
342 | $90 | $292 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
219 | $87 | $240 |
| Aflibercept eye injection (Eylea) | 196 | $687 | $1,329 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
180 | $404 | $1,795 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
168 | $247 | $685 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
164 | $7 | $44 |
| Bevacizumab injection, 10 mg Administration of a 10 mg dose of bevacizumab medication via injection. |
131 | $54 | $105 |
| CT scan of cornea A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye. |
124 | $24 | $174 |
| Extended color vision testing A comprehensive eye exam that includes specialized tests to evaluate color vision. |
102 | $40 | $75 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
85 | $16 | $92 |
| Eye deviation and range of motion exam An examination to measure eye deviation and assess the range of motion of the eyes. |
54 | $45 | $120 |
| Tear duct plug insertion A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface. |
44 | $118 | $364 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
42 | $11 | $75 |
| Removal of eye fluid | 37 | $92 | $574 |
| Eyelash removal with forceps This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area. |
35 | $13 | $189 |
| Nasal tear duct probing A procedure to examine and clear the tear ducts in the nose. It helps restore normal drainage of tears from the eye. |
23 | $122 | $417 |
| Eye photography Photographic imaging of the interior structures of the eye. |
21 | $12 | $88 |
| New patient eye exam, problem focused A focused examination of the visual system performed during a new patient visit. |
18 | $51 | $149 |
| Eyelid growth removal A procedure to remove a growth from the eyelid. |
15 | $195 | $627 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.2% high complexity
18.8% medium
79.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$212,233
Total received (2018-2024)
Avg $30,319/year across 7 years
Top 3% in TX for glaucoma specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
682
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$25,164
2023
$11,411
2022
$21,198
2021
$22,624
2020
$5,211
2019
$33,751
2018
$92,873
Payments by company (2024)
Bausch & Lomb Americas Inc.
$21,923
Carl Zeiss Meditec USA, Inc.
$770
Alcon Vision LLC
$462
ABBVIE INC.
$372
Tarsus Pharmaceuticals, Inc.
$240
Harrow Eye, LLC
$239
Sight Sciences, Inc.
$211
BIOTISSUE HOLDINGS INC.
$157
Johnson & Johnson Surgical Vision, Inc.
$152
Regeneron Pharmaceuticals, Inc.
$150
Ocular Therapeutix, Inc.
$126
Amgen Inc.
$118
Mallinckrodt Hospital Products Inc.
$69
Dompe US, Inc.
$56
Thea Pharma Inc.
$50
Astellas Pharma US Inc
$29
RECORDATI_RARE_DISEASES_INC.
$22
RxSight Inc
$19
Top 3 companies account for 92.0% of 2024 payments
All-time payments by company (2018-2024) ›
Bausch & Lomb, a division of Bausch Health US, LLC
$105,242
Bausch & Lomb Americas Inc.
$49,473
Novartis Pharmaceuticals Corporation
$30,076
Aerie Pharmaceuticals, Inc.
$6,026
Kala Pharmaceuticals, Inc.
$4,772
Regeneron Pharmaceuticals, Inc.
$2,450
Johnson & Johnson Surgical Vision, Inc.
$2,246
Alcon Vision LLC
$1,420
ABBVIE INC.
$1,383
Alcon Laboratories Inc
$1,264
Eyevance Pharmaceuticals LLC
$1,094
Sun Pharmaceutical Industries Inc.
$915
Carl Zeiss Meditec USA, Inc.
$804
Allergan, Inc.
$626
Horizon Therapeutics plc
$487
Allergan Inc.
$457
Shire North American Group Inc
$427
Sight Sciences, Inc.
$372
Oyster Point Pharma, Inc.
$365
Tarsus Pharmaceuticals, Inc.
$240
Harrow Eye, LLC
$239
Regeneron Healthcare Solutions, Inc.
$215
Glaukos Corporation
$188
TissueTech, Inc.
$176
BIOTISSUE HOLDINGS INC.
$157
Incyte Corporation
$153
Ocular Therapeutix, Inc.
$126
Amgen Inc.
$118
Thea Pharma Inc.
$117
SUN PHARMACEUTICAL INDUSTRIES INC.
$111
Beaver-Visitec International, Inc.
$83
Dompe US, Inc.
$79
Mallinckrodt Hospital Products Inc.
$69
Astellas Pharma US Inc
$64
Johnson & Johnson Vision Care, Inc.
$57
Optos, Inc.
$32
Mallinckrodt Enterprises LLC
$24
TISSUETECH, INC.
$23
RECORDATI_RARE_DISEASES_INC.
$22
CooperVision Inc.
$19
RxSight Inc
$19
Top 3 companies account for 87.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALREX · ARGOS · AcrySof · AcrySof IQ PanOptix · AcrySof IQ VIVITY IOL · Acuvue · BESIVANCE · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · COMBIGAN · Centurion · Cequa · Clareon · Clariti Contact Lens · CyPass · DEXTENZA · DUREZOL · DURYSTA · EYLEA · EYLEA HD · EYSUVIS · Flarex · HYDRUS Microstent · INVELTYS · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · Izervay · LOTEMAX · LOTEMAX SM · LUMERA · LUMERA 300 · LUMIGAN · LenSx · MIEBO · NEOX · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OPZELURA · OXERVATE · PANHEMATIN · PANORAMIC OPHTHALMOSCOPE · PAZEO · PROLENSA · Prokera · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · Rhopressa · Rocklatan · Simbrinza · TEARCARE SYSTEM · TENEO · TEPEZZA · TRAVATAN Z · TYRVAYA · TearCare · TearCare SmartLid · TearScience Activators · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Simplicity · Tecnis Symfony IOL · Tobradex ST · VEVYE · VICTUS · VUITY · VYZULTA · Winlevi · XDEMVY · XELPROS · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · rhopressa · rocklatan
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Glaucoma specialist physicians in nearby ZIP areas
8
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McMenemy is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McMenemy experienced with measurement of corneal pressure?
Based on Medicare claims data, Dr. McMenemy performed 4,030 measurement of corneal pressure services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McMenemy receive payments from pharmaceutical companies?
Yes. Dr. McMenemy received a total of $212,233 from 41 companies across 682 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McMenemy's costs compare to other glaucoma specialist physicians in Sugar Land?
Dr. McMenemy's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McMenemy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Glaucoma Specialist Physicians in Sugar Land
Browse glaucoma specialist physicians in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Glaucoma Specialist Physicians in TX
Glaucoma specialist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Glaucoma Specialist Physicians in TX
Which TX glaucoma specialist physicians receive the most from drug and device companies.
By company
Bausch & Lomb, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Bausch & Lomb, a division of Bausch Health US, LLC.
By company
Bausch & Lomb Americas Inc. Payments to Doctors
See all physicians who received payments from Bausch & Lomb Americas Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology